Sodium molybdate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name

Sodium molybdate

DrugBank Accession Number

DB14496

Background

Not Available

Type

Small Molecule

Groups

Approved, Experimental

Structure

Similar Structures

Weight: Average: 205.93
Monoisotopic: 207.864602
Chemical Formula: MoNa₂O₄

Synonyms

Anhydric sodium molybdate
Molybdenum (as sodium)
Sodium molybdate (anhydrous)
Sodium molybdate(VI)
Sodium molybdenum oxide

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Associated Conditions

Indication Type	Indication	Combined Product Details	Approval Level	Age Group	Dose Form
Diagnostic agent	Meckel diverticulum		••••••••••••		•••••••••
Used in combination as diagnostic agent	Meckel diverticulum	Combination Product in combination with: Technetium Tc-99m pertechnetate (DB09314), Water (DB09145), Sodium chloride (DB09153)	••••••••••••	•••••	••••••••
Diagnostic agent	Salivary gland disorder		••••••••••••		•••••••••
Diagnostic agent	Sjögren's syndrome		••••••••••••		•••••••••
Diagnostic agent	Thyroid diseases		••••••••••••		•••••••••

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: No interactions found.

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Product Ingredients

Ingredient	UNII	CAS	InChI Key
Sodium molybdate dihydrate	8F2SXI1704	10102-40-6	VXPCUCBABLNLFW-UHFFFAOYSA-L

Active Moieties

Name	Kind	UNII	CAS	InChI Key
Molybdate	ionic	O0L10E6352	14259-85-9	MEFBJEMVZONFCJ-UHFFFAOYSA-N

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
ADDAMEL INFUSION N	Sodium molybdate dihydrate (48.5 mcg) + Chromic chloride hexahydrate (53.3 mcg) + Cupric chloride dihydrate (3.4 mg) + Ferric chloride hexahydrate (5.4 mg) + Manganese chloride tetrahydrate (990 mcg) + Potassium Iodide (166 mcg) + Sodium selenite pentahydrate (105 mcg) + Sodium fluoride (2.1 mg) + Zinc chloride (13.6 mg)	Solution, concentrate	Intravenous	FRESENIUS KABI COLOMBIA S.A.S.	2006-11-10	2009-05-08
ADDAMEL N	Sodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (0.1 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (19.8 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (17.3 mcg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.05 mg/ml)	Injection, solution, concentrate	Intravenous	Fresenius Kabi Italia S.R.L.	2014-07-08	2020-05-12
ADDAMEL N FOR INFUSION	Sodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (0.34 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (99 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (6.9 mcg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.36 mg/ml)	Injection	Intravenous	FRESENIUS KABI (SINGAPORE) PTE LTD	1992-01-31	Not applicable
ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION	Sodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (102.3 mcg/ml) + Ferric chloride hexahydrate (540 mcg/ml) + Manganese chloride tetrahydrate (19.79 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (17.29 mcg/ml) + Sodium fluoride (210 mcg/ml) + Zinc chloride (1050 mcg/ml)	Solution	Intravenous	FRESENIUS KABI (SINGAPORE) PTE LTD	2017-07-24	Not applicable
Addaven Konzentrat zur Herstellung einer Infusionslösung	Sodium molybdate dihydrate (4.85 μg/ml) + Chromic chloride hexahydrate (5.33 μg/ml) + Cupric chloride dihydrate (0.1 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (19.8 μg/ml) + Potassium Iodide (16.6 μg/ml) + Sodium selenite (17.3 μg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.05 mg/ml)	Injection, solution, concentrate	Intravenous	Fresenius Kabi Austria Gmb H	2015-03-02	Not applicable

Unapproved/Other Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Addamel N	Sodium molybdate dihydrate (1.9 ug/1mL) + Chromic chloride hexahydrate (1 ug/1mL) + Cuprous chloride (0.13 mg/1mL) + Ferric chloride (0.11 mg/1mL) + Manganese chloride tetrahydrate (0.027 mg/1mL) + Potassium Iodide (0.013 mg/1mL) + Sodium selenite (3.2 ug/1mL) + Sodium fluoride (0.095 mg/1mL) + Zinc chloride (0.65 mg/1mL)	Injection, solution	Intravenous	Fresenius Kabi USA, LLC	2013-05-07	2017-03-31
ADDAMEL N 20 AMPUL	Sodium molybdate (48.5 mcg/10mL) + Chromic chloride (53.3 mcg/10mL) + Cupric Chloride (3.4 mg/10mL) + Ferric chloride (5.4 mg/10mL) + Manganese chloride (990 mcg/10mL) + Potassium Iodide (166 mcg/10mL) + Sodium selenite (69 mcg/10mL) + Sodium fluoride (2.1 mg/10mL) + Zinc chloride (13.6 mg/10mL)	Injection, solution	Intravenous	FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ.	2019-04-30	Not applicable
ADDAVEN IV INFUZYON ICIN KONSANTRE SOLUSYON	Sodium molybdate (48.5 mcg/10mL) + Chromic chloride (53.3 mcg/10mL) + Cupric Chloride (1.02 mg/10mL) + Ferric chloride (5.4 mg/10mL) + Manganese chloride (198 mcg/10mL) + Potassium Iodide (166 mcg/10mL) + Sodium selenite (173 mcg/10mL) + Sodium fluoride (2.1 mg/10mL) + Zinc chloride (10.5 mg/10mL)	Injection, solution	Intravenous	FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ.	2016-09-06	2022-11-10
Tricare Prenatal 2-part Daily Prenatal Vitamin System	Sodium molybdate (.0375 mg/1) + Ascorbic acid (30 mg/1) + Biotin (.150 mg/1) + Cholecalciferol (400 [iU]/1) + Chromium Cr-51 chloride (.060 mg/1) + Copper gluconate (1 mg/1) + Cyanocobalamin (.125 mg/1) + Doconexent (150 1/1) + Ferric pyrophosphate (4.5 mg/1) + Icosapent (37.5 1/1) + Levomefolic acid (1 mg/1) + Manganese citrate decahydrate (1 mg/1) + Nicotinamide (10 mg/1) + Omega-3 fatty acids (75 1/1) + Calcium pantothenate (5 mg/1) + Pyridoxine hydrochloride (2.5 mg/1) + Riboflavin (.85 mg/1) + Sodium selenite (.0325 mg/1) + Thiamine mononitrate (1.25 mg/1) + Zinc (7 mg/1) + alpha-Tocopherol succinate (15 [iU]/1)	Kit	Oral	Medecor Pharma, Llc	2016-05-10	Not applicable

Chemical Identifiers

UNII: 948QAQ08I1
CAS number: 7631-95-0
InChI Key: TVXXNOYZHKPKGW-UHFFFAOYSA-N
InChI: InChI=1S/Mo.2Na.4O/q;2*+1;;;2*-1
IUPAC Name: disodium dioxomolybdenumbis(olate)
SMILES: [Na+].[Na+].[O-][Mo]([O-])(=O)=O

References

General References

Not Available

External Links

KEGG Compound: C15455
ChemSpider: 55350
RxNav: 36699
ChEBI: 75215
Wikipedia: Sodium_molybdate

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count
1, 2	Completed	Prevention	Deficiency, Vitamin D / Pre-Eclampsia	1
Not Available	Recruiting	Not Available	COVID-19, Long Haul / Long Haul COVID / Post-Acute COVID-19 / Post-acute COVID-19 (PACS), or "Long COVID" Syndrome	1

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Solution, concentrate	Intravenous
Injection, solution	Intravenous
Injection, solution, concentrate	Intravenous
Injection	Intravenous	5.33 mcg/ml
Injection, solution	Intravenous drip
Solution	Intravenous	5.33 mcg/ml
Capsule	Oral
Powder	Oral
Tablet, film coated
Solution	Intravenous
Solution	Intravenous	50 GBq
Liquid	Oral
Capsule, liquid filled	Oral
Solution	Intravenous	0.053 mg/10ml
Tablet	Oral
Injection, solution	Parenteral
Kit	Oral
Tablet, chewable	Oral
Solution	Intraocular; Intravenous
Capsule, gelatin coated	Oral

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source
logP	-1.8	Chemaxon
pKa (Strongest Acidic)	-2.3	Chemaxon
Physiological Charge	-2	Chemaxon
Hydrogen Acceptor Count	4	Chemaxon
Hydrogen Donor Count	0	Chemaxon
Polar Surface Area	80.26 Å²	Chemaxon
Rotatable Bond Count	0	Chemaxon
Refractivity	5.77 m³·mol^-1	Chemaxon
Polarizability	6.04 Å³	Chemaxon
Number of Rings	0	Chemaxon
Bioavailability	1	Chemaxon
Rule of Five	Yes	Chemaxon
Ghose Filter	No	Chemaxon
Veber's Rule	No	Chemaxon
MDDR-like Rule	No	Chemaxon

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST): Not Available
Spectra: Not Available
Chromatographic Properties: Collision Cross Sections (CCS)
Not Available

Drug created at July 09, 2018 20:01 / Updated at October 06, 2020 04:50

Sodium molybdate

Identification

Structure for Sodium molybdate (DB14496)

Pharmacology

Interactions

Products

Categories

Chemical Identifiers

References

Clinical Trials

Pharmacoeconomics

Properties

Spectra

Collision Cross Sections (CCS)